Sentinel 3.0_2026 Updated Market Research
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) is conducting market research for its Sentinel 3.0 program to inform acquisition planning. This Sources Sought notice specifically seeks information on commercial market capabilities for a Data Broker-led acquisition model to support Tiers 1-6 (Data Partners), focusing on acquiring, aggregating, de-identifying, governing, licensing, and facilitating access to diverse healthcare data. Responses are due March 23, 2026, by 10:00 pm EST.
Scope of Work
The FDA anticipates a three-contract structure for Sentinel 3.0:
- Contract 1 (Data Partners - Tiers 1-6): Data Broker-led model for acquiring, licensing, governing, and providing access to multiple types of healthcare data (e.g., commercial claims, EHR-linked, registry, CMS, outpatient prescription data). The prime contractor will be responsible for all data delivered, including coordination with third-party providers.
- Contract 2 (GOCO Platform - Tier 7): Government-Owned, Contractor-Operated platform for data repository, interoperability, and informatics tools.
- Contract 3 (Scientific Support Services - Tier 8): Provision of scientific services, including complex pharmacoepidemiology and pharmacovigilance studies and advanced analytics.
This market research specifically targets capabilities for Contract 1, requiring expertise in acquiring, aggregating, de-identifying, governing, licensing, and facilitating access to healthcare data across multiple types and sources, potentially managing third-party data providers.
Contract & Timeline
- Type: Sources Sought / Market Research (not an RFP/RFQ/IFB).
- NAICS: Anticipated NAICS code is 518210 (Computing Infrastructure Providers, Data Processing, Web Hosting, And Related Services).
- Set-Aside: Not explicitly stated, but respondents are asked to provide business size and classification.
- Response Due: March 23, 2026, by 10:00 pm EST.
- Published: March 3, 2026.
Submission & Evaluation
Interested parties should submit responses to specific questions regarding data availability, pricing constructs, licensing preferences, user-based subscription pricing, and resource models. Submissions must also include a company profile, contact information, existing contract details (if applicable), and a capability statement. Recommendations for optimizing draft attachments (Pricing Structure, PWS, Agency Requirements, Terms and Conditions) are also requested. Capability statements and answers to questions 1-5 are limited to 10 pages.
Additional Notes
This notice supersedes a previous market research notice (FDARFI5302025). Draft attachments, including a Performance Work Statement (PWS) and a Data Characteristics Table, are provided for context and feedback. The primary contact is Narissa Charles at narissa.charles@fda.hhs.gov.